These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 5504562)

  • 1. [L-dopa treatment of Parkinson's disease. Results after one year].
    Dalle Ore G; Da Pian R; Bazzan A; Giombini S; Solero CL; Maschio A
    Sist Nerv; 1970; 22(2):92-8. PubMed ID: 5504562
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of L-dopa treatment in 117 patients with Parkinson's disease followed for 1 year or more].
    Bonduelle M; Bouygues P; Lormeau G; de Maricourt C
    Rev Neurol (Paris); 1972 Aug; 127(2):309-11. PubMed ID: 4666637
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of Parkinson's disease by L-DOPA].
    Barbeau A
    Union Med Can; 1969 Feb; 98(2):183-6. PubMed ID: 5773394
    [No Abstract]   [Full Text] [Related]  

  • 4. [L-dopa in the treatment of Parkinson's disease].
    Völler G
    Med Welt; 1970 Jul; 27():1267-8. PubMed ID: 5512643
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease].
    Lakke JP; Nienhuis RJ; Meyer R; Zwols F; Schut T
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2180-4. PubMed ID: 4639072
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parkinson's syndrome. 7. Experiences with L-dopa-treatment].
    Svanborg A
    Lakartidningen; 1970 Oct; 67(42):4827-31. PubMed ID: 5478708
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary observations on the use of L-DOPA in the treatment of the akinetic symptoms of Parkinson's disease].
    Uriciuoli R; Nivoli GC
    Minerva Med; 1968 May; 59(43):2516-21. PubMed ID: 5664430
    [No Abstract]   [Full Text] [Related]  

  • 9. [L-Dopa in the treatment of Parkinson's disease].
    Warot P
    Lille Med; 1971; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract]   [Full Text] [Related]  

  • 10. L-dopa in Parkinson's disease.
    Cleghorn RA
    Can Med Assoc J; 1970 Jun; 102(13):1410 passim. PubMed ID: 5422440
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of Parkinson's disease with L-dopa].
    Dalle Ore G; Bricolo A; Robotti E; Bazzan A; Mazza C
    Policlinico Prat; 1970 Apr; 77(16):509-24. PubMed ID: 5443873
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
    Audelman JU; Hoel RL; Lassman FM
    Neurology; 1970 Apr; 20(4):410-1. PubMed ID: 5535064
    [No Abstract]   [Full Text] [Related]  

  • 13. L-dopa therapy in Parkinson's disease.
    Murray TJ
    N S Med Bull; 1972 Jun; 51(3):67-70. PubMed ID: 4504954
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in saccadic eye movements of patients with Parkinson's disease before and after L-dopa.
    Highstein S; Cohen B; Mones R
    Trans Am Neurol Assoc; 1969; 94():277-9. PubMed ID: 5374461
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Parkinson's disease with L-dopa therapy.
    Tyler E
    Can Nurse; 1971 Apr; 67(4):41-2. PubMed ID: 5549360
    [No Abstract]   [Full Text] [Related]  

  • 16. [L-dopa in the treatment of Parkinson's disease. Preliminary report].
    Poch GF
    Prensa Med Argent; 1969 Oct; 56(34):1629-32. PubMed ID: 5405572
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 18. [Parkinson's disease treated with L-DOPA].
    Berg-Jensen B
    Nord Med; 1971 Dec; 86(48):1440-1. PubMed ID: 5133987
    [No Abstract]   [Full Text] [Related]  

  • 19. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease].
    Gomirato G; Perfetti C
    Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of psychometic tests in 23 patients with Parkinson's disease after 6 months treatment with L-dopa].
    Barbizet J; Duizabo P; Pasquier M
    Rev Neurol (Paris); 1972 Aug; 127(2):311-3. PubMed ID: 4666638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.